Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.

23
Number of overlapping holdings
82.1%
% of PBE's 28 holdings also in IBB
10.3%
% of IBB's 261 holdings also in PBE
Overlap by Weight
Sector Drift (PBE minus IBB)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
Company | Weight in PBE |
Weight in IBB |
Overlap | |
---|---|---|---|---|
GILEAD SCIENCES INC | 5.1% | 8.2% | 5.1% | |
AMGEN INC | 5.0% | 8.4% | 5.0% | |
REGENERON PHARMACEUTICALS | 4.5% | 7.3% | 4.5% | |
BIOGEN IDEC INC | 5.0% | 2.2% | 2.2% | |
NATERA INC | 4.7% | 2.0% | 2.0% |
Position Highlights (Non-Overlapping Exposures)
PBE Overweight Relative to IBB
TG THERAPEUTICS INC | 3.8% | |
NEUROCRINE BIOSCIENCES INC | 3.8% | |
PROTAGONIST THERAPEUTICS, INC. | 3.6% | |
CATALYST PHARMACEUTICAL PART | 3.3% | |
UNITED THERAPEUTICS CORP | 2.9% | |
ILLUMINA INC | 2.9% | |
COLLEGIUM PHARMACEUTICAL, INC. | 2.9% | |
BIOGEN IDEC INC | 2.7% | |
NATERA INC | 2.7% | |
DYNAVAX TECHNOLOGIES CORP | 2.7% |
PBE Underweight Relative to IBB
VERTEX PHARMACEUTICALS INC | -8.6% | |
ALNYLAM PHARMACEUTICALS INC | -3.6% | |
IQVIA HOLDINGS INC | -3.4% | |
AMGEN INC | -3.4% | |
GILEAD SCIENCES INC | -3.1% | |
REGENERON PHARMACEUTICALS | -2.8% | |
ARGENX SE ADR | -2.7% | |
METTLER-TOLEDO INTERNATIONAL | -2.6% | |
WATERS CORP | -2.3% | |
BIONTECH SE SPONSORED ADR | -1.7% |